These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 675588)

  • 1. Sugar derivatives of indolamines, part II: difference in the oxidation of serotonin and its desoxyfructose derivative by rat brain monoamine oxidase.
    Bhargava KP; Gujrati VR; Ali B; Mester M; Mester L
    Thromb Res; 1978 May; 12(5):791-5. PubMed ID: 675588
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of iprazid and transamine on monoamine oxidase activity and monoamine content on the brain of dogs and rabbits].
    Kocherga VI; Gotovtseva EP
    Ukr Biokhim Zh; 1967; 39(2):125-9. PubMed ID: 5603055
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.
    Celada P; Artigas F
    J Neurochem; 1993 Dec; 61(6):2191-8. PubMed ID: 7504085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO).
    Fitzgerald DH; Tipton KF
    J Neural Transm (Vienna); 2002 Mar; 109(3):251-65. PubMed ID: 11956949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
    Popov N; Matthies H
    Acta Biol Med Ger; 1966; 17(5):637-43. PubMed ID: 5991588
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of tranylcypromine on glycogenolysis in the rat brain].
    Rinaudo MT; Curto M; Bruno R; Torre E; Bogetto F; Torre M
    Boll Soc Ital Biol Sper; 1979 Jan; 55(2):148-52. PubMed ID: 17955640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 9. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration.
    Sherry-McKenna RL; Baker GB; Mousseau DD; Coutts RT; Dewhurst WG
    Biol Psychiatry; 1992 May; 31(9):881-8. PubMed ID: 1353376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tranylcypromine upon 5-hydroxytryptaminergic neurons of rat brain stem.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1966; 14(4):365-70. PubMed ID: 5952329
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin-containing neurons in brain: depression of firing by monoamine oxidase inhibitors.
    Aghajanian GK; Graham AW; Sheard MH
    Science; 1970 Sep; 169(3950):1100-2. PubMed ID: 5449322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of monoamine oxidase in rat brain mitochondria.
    Fuller RW; Warren BJ; Molloy BB
    Biochem Pharmacol; 1970 Nov; 19(11):2934-6. PubMed ID: 5512701
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between the pharmacological and biochemical properties of a monoamine oxidase inhibitor preferentially affecting 5-hydroxytryptamine oxidation.
    Christmas AJ; Hall DW; Hayward A; Maxwell DR
    Br J Pharmacol; 1970 May; 39(1):207P-208P. PubMed ID: 5420104
    [No Abstract]   [Full Text] [Related]  

  • 15. [Various effects of monoamine oxidase inhibitors under conditions of complete monoamine oxidase inhibition on the serotonin, dopamine and noradrenaline levels in the rat brain].
    Matthies H; Popov N
    Acta Biol Med Ger; 1966; 17(4):488-97. PubMed ID: 5983631
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of certain psychopharmaca on intraneuronal levels of 5-HT and catecholamines in the specific monoamine neurons of the rat brain.
    Bartonicék V; Dahlström A; Fuxe K
    Experientia; 1964 Dec; 20(12):690-1. PubMed ID: 5858602
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular background and physiological consequences of altered peripheral serotonin homeostasis in adult rats perinatally treated with tranylcypromine.
    Blazevic S; Erjavec I; Brizic M; Vukicevic S; Hranilovic D
    J Physiol Pharmacol; 2015 Aug; 66(4):529-37. PubMed ID: 26348077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of monoamine oxidase inhibitors on the concentrations of dopamine and serotonin in the striatum of the cat with and without unilateral brainstem lesions.
    Singh P; Poirier LJ; Boucher R
    Can J Physiol Pharmacol; 1967 Sep; 45(5):897-904. PubMed ID: 6049616
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoamine oxidation in different regions of rat & goat brain.
    Guha SR; Bose AR; Ghosh SK
    Indian J Biochem; 1971 Sep; 8(3):170-1. PubMed ID: 4257874
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoamine oxidase inhibitory properties of milacemide in rats.
    Truong DD; Diamond B; Pezzoli G; Mena MA; Fahn S
    Life Sci; 1989; 44(15):1059-66. PubMed ID: 2784529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.